Atsena Therapeutics: Dual Vector animation. MoA animation

See full case study: https://m.visual-science.co/atsena-therapeutics-vector/case-study

We used our most advanced high-end 3D animation, combined with a 2D explainer overlay. We believe this combination is optimal for clear presentation of the molecular mechanism of action to investors. The 3D animation is scientifically rigorous and eye-catching, and the 2D part is an elegant way of demonstrating the main principle.

We are grateful to Patrick Ritschel (CEO at Atsena Therapeutics) for working with us, and for his kind feedback: "We are very pleased with Visual Science — they are a very responsive group to work with, and the final product is exactly what we had envisioned."
Atsena Therapeutics is a clinical-stage gene therapy company focused on leveraging the life-changing power of genetic medicine to reverse or prevent blindness.

Atsena Therapeutics’ platform is powered by adeno-associated virus (AAV) vectors engineered for the treatment of inherited retinal diseases. The platform includes capsids for subretinal injection, mediating transgene expression which spreads laterally across the tissue. Lateral spread of the capsids ensures delivery of genes to wide areas of the retina, alongside safe delivery to the foveal cones

Видео Atsena Therapeutics: Dual Vector animation. MoA animation канала Visual Science